MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 584467 | Name: Cloflucarban
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cloflucarban is a disinfectant agent.

Chemical Structure

Cloflucarban
Cloflucarban
CAS#369-77-7

Theoretical Analysis

MedKoo Cat#: 584467

Name: Cloflucarban

CAS#: 369-77-7

Chemical Formula: C14H9Cl2F3N2O

Exact Mass: 348.0044

Molecular Weight: 349.13

Elemental Analysis: C, 48.16; H, 2.60; Cl, 20.31; F, 16.32; N, 8.02; O, 4.58

Price and Availability

Size Price Availability Quantity
250mg USD 450.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Cloflucarban; Cloflucarbon; Irgasan CF3; Halocarban
IUPAC/Chemical Name
1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-chlorophenyl)urea
InChi Key
ZFSXZJXLKAJIGS-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H9Cl2F3N2O/c15-8-1-3-9(4-2-8)20-13(22)21-10-5-6-12(16)11(7-10)14(17,18)19/h1-7H,(H2,20,21,22)
SMILES Code
O=C(NC1=CC=C(Cl)C=C1)NC2=CC=C(Cl)C(C(F)(F)F)=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 349.13 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Riber L, Burmølle M, Alm M, Milani SM, Thomsen P, Hansen LH, Sørensen SJ. Enhanced plasmid loss in bacterial populations exposed to the antimicrobial compound irgasan delivered from interpenetrating polymer network silicone hydrogels. Plasmid. 2016 Sep - Nov;87-88:72-78. doi: 10.1016/j.plasmid.2016.10.001. Epub 2016 Oct 12. PubMed PMID: 27743797. 2: Thuan NK, Naher K, Kubo R, Taniguchi T, Hayashidani H. Evaluation of Chromogenic Medium for Selective Isolation of Yersinia. Shokuhin Eiseigaku Zasshi. 2016;57(5):166-168. PubMed PMID: 27784868. 3: G Archana, Dhodapkar R, Kumar A. Offline solid-phase extraction for preconcentration of pharmaceuticals and personal care products in environmental water and their simultaneous determination using the reversed phase high-performance liquid chromatography method. Environ Monit Assess. 2016 Sep;188(9):512. doi: 10.1007/s10661-016-5510-1. Epub 2016 Aug 9. PubMed PMID: 27502523. 4: Nishi K, Suzuki K, Sawamoto J, Tokizawa Y, Iwase Y, Yumita N, Ikeda T. Inhibition of Fatty Acid Synthesis Induces Apoptosis of Human Pancreatic Cancer Cells. Anticancer Res. 2016 Sep;36(9):4655-60. PubMed PMID: 27630308. 5: Tan LK, Ooi PT, Carniel E, Thong KL. Evaluation of a modified Cefsulodin-Irgasan-Novobiocin agar for isolation of Yersinia spp. PLoS One. 2014 Aug 29;9(8):e106329. doi: 10.1371/journal.pone.0106329. eCollection 2014. PubMed PMID: 25170941; PubMed Central PMCID: PMC4149559. 6: Altwegg M, Zollinger-Iten J, von Graevenitz A. Differentiation of Kluyvera cryocrescens from Kluyvera ascorbata by irgasan susceptibility testing. Ann Inst Pasteur Microbiol (1985). 1986 Mar-Apr;137A(2):159-68. PubMed PMID: 3426156. 7: González M, Gude MJ, Seral C, Abad MP, Algarate S, Castillo FJ. [Comparasion of two methods for recovery of Aeromonas spp. in feces from agar CIN (Cefsulodin-Irgasan-Novobiocin)]. Rev Esp Quimioter. 2010 Dec;23(4):217-8. Spanish. PubMed PMID: 21191564. 8: Rudzok S, Schlink U, Herbarth O, Bauer M. Measuring and modeling of binary mixture effects of pharmaceuticals and nickel on cell viability/cytotoxicity in the human hepatoma derived cell line HepG2. Toxicol Appl Pharmacol. 2010 May 1;244(3):336-43. doi: 10.1016/j.taap.2010.01.012. Epub 2010 Feb 2. PubMed PMID: 20132835. 9: Neyts K, Notebaert E, Uyttendaele M, Debevere J. Modification of the bile salts-Irgasan-brilliant green agar for enumeration of Aeromonas species from food. Int J Food Microbiol. 2000 Jun 15;57(3):211-8. PubMed PMID: 10868682. 10: Kingston D, Hill ID. Elution of disinfectant from polyurethane cannula tubing. J Hosp Infect. 1990 Oct;16(3):271-80. PubMed PMID: 1979578. 11: Rüttermann S, Trellenkamp T, Bergmann N, Beikler T, Ritter H, Janda R. Bacterial viability and physical properties of antibacterially modified experimental dental resin composites. PLoS One. 2013 Nov 1;8(11):e79119. doi: 10.1371/journal.pone.0079119. eCollection 2013. Erratum in: PLoS One. 2015;10(5):e0126198. PubMed PMID: 24223890; PubMed Central PMCID: PMC3815119. 12: De Zutter L, Le Mort L, Janssens M, Wauters G. Short-comings of irgasan ticarcillin chlorate broth for the enrichment of Yersinia enterocolitica biotype 2, serotype 9 from meat. Int J Food Microbiol. 1994 Oct;23(2):231-7. PubMed PMID: 7848786. 13: Toora S, Budu-Amoako E, Ablett RF, Smith J. Evaluation of different antimicrobial agents used as selective supplements for isolation and recovery of Yersinia enterocolitica. J Appl Bacteriol. 1994 Jul;77(1):67-72. PubMed PMID: 7928783. 14: Pyle JA, Warwick NJ, Harris NR, Abas MR, Archibald AT, Ashfold MJ, Ashworth K, Barkley MP, Carver GD, Chance K, Dorsey JR, Fowler D, Gonzi S, Gostlow B, Hewitt CN, Kurosu TP, Lee JD, Langford SB, Mills G, Moller S, MacKenzie AR, Manning AJ, Misztal P, Nadzir MS, Nemitz E, Newton HM, O'Brien LM, Ong S, Oram D, Palmer PI, Peng LK, Phang SM, Pike R, Pugh TA, Rahman NA, Robinson AD, Sentian J, Samah AA, Skiba U, Ung HE, Yong SE, Young PJ. The impact of local surface changes in Borneo on atmospheric composition at wider spatial scales: coastal processes, land-use change and air quality. Philos Trans R Soc Lond B Biol Sci. 2011 Nov 27;366(1582):3210-24. doi: 10.1098/rstb.2011.0060. PubMed PMID: 22006963; PubMed Central PMCID: PMC3179638. 15: Altorfer R, Altwegg M, Zollinger-Iten J, von Graevenitz A. Growth of Aeromonas spp. on cefsulodin-Irgasan-novobiocin agar selective for Yersinia enterocolitica. J Clin Microbiol. 1985 Oct;22(4):478-80. PubMed PMID: 4077959; PubMed Central PMCID: PMC268447. 16: Kingston D, Seal DV, Hill ID. Self-disinfecting plastics for intravenous catheters and prosthetic inserts. J Hyg (Lond). 1986 Apr;96(2):185-98. PubMed PMID: 3517154; PubMed Central PMCID: PMC2129647. 17: Kanetoshi A, Ogawa H, Katsura E, Okui T, Kaneshima H. Disposition and excretion of Irgasan DP300 and its chlorinated derivatives in mice. Arch Environ Contam Toxicol. 1988 Sep;17(5):637-44. PubMed PMID: 3214192. 18: Devenish JA, Schiemann DA. An abbreviated scheme for identification of Yersinia enterocolitica isolated from food enrichments on CIN (cefsulodin-irgasan-novobiocin) agar. Can J Microbiol. 1981 Sep;27(9):937-41. PubMed PMID: 7306881. 19: Fonseca K, MacDougall J, Pitt TL. Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media. J Clin Pathol. 1986 Feb;39(2):220-2. PubMed PMID: 3081597; PubMed Central PMCID: PMC499682. 20: Meincke BE, Kranz RG, Lynch DL. Effect of irgasan on bacterial growth and its adsorption into the cell wall. Microbios. 1980;28(113-114):133-47. PubMed PMID: 6787394.

View History

Clofeverine hydrochloride

Clofeverine hydrochloride